EW
OYST

Evoke Wealth’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Evoke Wealth’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-320
Closed -$6K – 1239
2021
Q2 		$6K Buy
+320
New +$6.08K ﹤0.01% 853

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Evoke Wealth's OYST Position: Q3 2021 in Review

Evoke Wealth sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2021, closing a stake of 320 shares — an estimated $6K sold.

Evoke Wealth first reported a position in OYST in Q2 2021 and held it in 1 quarter. The position peaked at $6K in Q2 2021. 69 funds tracked by Wall St. Rank hold OYST as of Q3 2021.

  • Evoke Wealth reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Evoke Wealth sold 320 Oyster Point Pharma, Inc. Common Stock shares in Q3 2021, an estimated $6K.
  • Evoke Wealth first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Evoke Wealth's Oyster Point Pharma, Inc. Common Stock position peaked at $6K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2021.

Based on Evoke Wealth's 13F filing for Q3 2021, filed 12 Nov 2021.